Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.

Schäfer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ.

Rheumatology (Oxford). 2010 Nov;49(11):2104-8. doi: 10.1093/rheumatology/keq200.

2.

Malignancy risk in patients with giant cell arteritis: a population-based cohort study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ.

Arthritis Care Res (Hoboken). 2010 Feb;62(2):149-54. doi: 10.1002/acr.20062.

3.

Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.

Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL.

J Rheumatol. 2014 Dec;41(12):2447-51. doi: 10.3899/jrheum.140124.

4.

Cancer preceding giant cell arteritis: a case-control study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Ytterberg SR, Matteson EL, Gabriel SE, Warrington KJ.

Arthritis Rheum. 2010 Jun;62(6):1763-9. doi: 10.1002/art.27429.

5.

Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.

Lo Gullo A, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Saitta A, Salvarani C, Matteson EL, Warrington KJ.

PLoS One. 2016 Feb 22;11(2):e0149579. doi: 10.1371/journal.pone.0149579.

6.

Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.

Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL.

Ann Rheum Dis. 2013 Dec;72(12):1989-94. doi: 10.1136/annrheumdis-2012-202408.

7.

Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study.

Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):396-402. doi: 10.1002/acr.22416.

8.

Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.

Amiri N, De Vera M, Choi HK, Sayre EC, Avina-Zubieta JA.

Rheumatology (Oxford). 2016 Jan;55(1):33-40. doi: 10.1093/rheumatology/kev262.

9.

The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.

Aviña-Zubieta JA, Bhole VM, Amiri N, Sayre EC, Choi HK.

Ann Rheum Dis. 2016 Jan;75(1):148-54. doi: 10.1136/annrheumdis-2014-205665.

PMID:
25265937
10.

Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.

Petri H, Nevitt A, Sarsour K, Napalkov P, Collinson N.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):390-5. doi: 10.1002/acr.22429.

11.

Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.

Michet CJ 3rd, Achenbach SJ, Crowson CS, Matteson EL.

Semin Arthritis Rheum. 2015 Aug;45(1):70-4. doi: 10.1016/j.semarthrit.2015.02.010.

12.

Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.

Pugnet G, Sailler L, Bourrel R, Montastruc JL, Lapeyre-Mestre M.

J Rheumatol. 2015 Feb;42(2):316-22. doi: 10.3899/jrheum.140906.

PMID:
25512477
13.

Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.

Ninan J, Nguyen AM, Cole A, Rischmueller M, Dodd T, Roberts-Thomson P, Hill CL.

J Rheumatol. 2011 Oct;38(10):2215-7. doi: 10.3899/jrheum.101254.

PMID:
21844141
14.

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.

Robson JC, Kiran A, Maskell J, Hutchings A, Arden N, Dasgupta B, Hamilton W, Emin A, Culliford D, Luqmani RA.

Ann Rheum Dis. 2015 Jan;74(1):129-35. doi: 10.1136/annrheumdis-2013-204113.

PMID:
24095936
15.

Incidence of infections in patients with giant cell arteritis: a cohort study.

Durand M, Thomas SL.

Arthritis Care Res (Hoboken). 2012 Apr;64(4):581-8. doi: 10.1002/acr.21569.

16.

Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

González-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J.

Ann Rheum Dis. 2001 Apr;60(4):367-71.

17.

Cancer in biopsy-proven giant cell arteritis. A population-based study.

Gonzalez-Gay MA, Lopez-Diaz MJ, Martinez-Lado L, Peña-Sagredo JL, Lopez-Agreda H, Miranda-Filloy JA, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J, Llorca J.

Semin Arthritis Rheum. 2007 Dec;37(3):156-63.

PMID:
17509668
18.
19.

Statin use in giant cell arteritis: a retrospective study.

Schmidt J, Kermani TA, Muratore F, Crowson CS, Matteson EL, Warrington KJ.

J Rheumatol. 2013 Jun;40(6):910-5. doi: 10.3899/jrheum.121150.

20.

A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS.

Mayo Clin Proc. 2007 Nov;82(11):1341-9. Erratum in: Mayo Clin Proc. 2008 Feb;83(2):255.

PMID:
17976353
Items per page

Supplemental Content

Support Center